Peapod Lane Capital LLC An2 Therapeutics, Inc. Transaction History
Peapod Lane Capital LLC
- $112 Billion
- Q3 2025
A detailed history of Peapod Lane Capital LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 589,216 shares of ANTX stock, worth $671,706. This represents 0.67% of its overall portfolio holdings.
Number of Shares
589,216
Previous 582,770
1.11%
Holding current value
$671,706
Previous $618 Million
21.14%
% of portfolio
0.67%
Previous 0.62%
Shares
4 transactions
Others Institutions Holding ANTX
# of Institutions
35Shares Held
7.57MCall Options Held
0Put Options Held
0-
Almitas Capital LLC Santa Monica, CA1.43MShares$1.63 Million0.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$1.23 Million0.0% of portfolio
-
Stonepine Capital Management, LLC Bend, OR564KShares$642,8600.58% of portfolio
-
Bank Of Nova Scotia459KShares$523,4810.0% of portfolio
-
Landscape Capital Management, L.L.C.456KShares$520,3670.04% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $22.1M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...